{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:54:44Z","timestamp":1789898084125,"version":"4.0.1"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1038\/nrc885","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T16:33:53Z","timestamp":1031070833000},"page":"673-682","source":"Crossref","is-referenced-by-count":726,"title":["Molecular basis of the VHL hereditary cancer syndrome"],"prefix":"10.1038","volume":"2","author":[{"suffix":"Jr","given":"William G.","family":"Kaelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrc885_CR1","first-page":"141","volume":"14","author":"ET Collins","year":"1894","unstructured":"Collins, E. T. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. UK 14, 141\u2013149 (1894).","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"BFnrc885_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF01994821","volume":"59","author":"E von Hippel","year":"1904","unstructured":"von Hippel, E. Ueber eine sehr seltene Erkrankung der Nethaut. Graefe Arch. Ophthalmol. 59, 83\u2013106 (1904).","journal-title":"Graefe Arch. Ophthalmol."},{"key":"BFnrc885_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1755-3768.1926.tb07786.x","volume":"4","author":"A Lindau","year":"1927","unstructured":"Lindau, A. Zur Frage der Angiomatosis Retinae und Ihrer Hirncomplikation. Acta Ophthalmol. 4, 193\u2013226 (1927).","journal-title":"Acta Ophthalmol."},{"key":"BFnrc885_CR4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2796.1998.00337.x","volume":"243","author":"S Richard","year":"1998","unstructured":"Richard, S., Campello, C., Taillandier, L., Parker, F. & Resche, F. Haemangioblastoma of the central nervous system in von Hippel\u2013Lindau disease. J. Intern. Med. 243, 547\u2013553 (1998).","journal-title":"J. Intern. Med."},{"key":"BFnrc885_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005792-199711000-00001","volume":"76","author":"E Maher","year":"1997","unstructured":"Maher, E. & Kaelin, W. G. von Hippel\u2013Lindau disease. Medicine 76, 381\u2013391 (1997).","journal-title":"Medicine"},{"key":"BFnrc885_CR6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/332268a0","volume":"332","author":"BR Seizinger","year":"1988","unstructured":"Seizinger, B. R. et al. Von Hippel\u2013Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332, 268\u2013269 (1988).","journal-title":"Nature"},{"key":"BFnrc885_CR7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif, F. et al. Identification of the von Hippel\u2013Lindau disease tumor suppressor gene. Science 260, 1317\u20131320 (1993).Describes the identification and cloning of the  VHL  tumour-suppressor gene. The gene was authenticated by the demonstration of intragenic mutations in affected members of VHL kindreds.","journal-title":"Science"},{"key":"BFnrc885_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/geno.2000.6144","volume":"65","author":"E Woodward","year":"2000","unstructured":"Woodward, E. et al. Comparative sequence analysis of the VHL tumor suppressor gene. Genomics 65, 253\u2013265 (2000).","journal-title":"Genomics"},{"key":"BFnrc885_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"A Epstein","year":"2001","unstructured":"Epstein, A. et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43\u201354 (2001).This paper, along with reference  10 , shows that the  C. elegans  and  Drosophila egl-9  genes, hydroxylate the HIF-\u03b1 proteins that are identified in these two species, respectively, and that the three human EGL-9 orthologues can hydroxylate human HIF-1\u03b1  in vitro.","journal-title":"Cell"},{"key":"BFnrc885_CR10","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"R Bruick","year":"2001","unstructured":"Bruick, R. & McKnight, S. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337\u20131340 (2001).","journal-title":"Science"},{"key":"BFnrc885_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K","volume":"12","author":"C Stolle","year":"1998","unstructured":"Stolle, C. et al. Improved detection of germline mutations in the von Hippel\u2013Lindau disease tumor suppressor gene. Hum. Mutat. 12, 417\u2013423 (1998).","journal-title":"Hum. Mutat."},{"key":"BFnrc885_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/humu.1380050109","volume":"5","author":"F Chen","year":"1995","unstructured":"Chen, F. et al. Germline mutations in the von Hippel\u2013Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5, 66\u201375 (1995).","journal-title":"Hum. Mutat."},{"key":"BFnrc885_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","volume":"8","author":"B Zbar","year":"1996","unstructured":"Zbar, B. et al. Germline mutations in the von Hippel\u2013Lindau (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8, 348\u2013357 (1996).","journal-title":"Hum. Mutat."},{"key":"BFnrc885_CR14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2796.1998.00336.x","volume":"243","author":"H Neumann","year":"1998","unstructured":"Neumann, H. & Bender, B. Genotype\u2013phenotype correlations in von Hippel\u2013Lindau disease. J. Intern. Med. 243, 541\u2013545 (1998).","journal-title":"J. Intern. Med."},{"key":"BFnrc885_CR15","first-page":"4845","volume":"54","author":"H Kanno","year":"1994","unstructured":"Kanno, H. et al. Somatic mutations of the von Hippel\u2013Lindau tumor supressor gene in sporadic central nervous systems hemangioblastomas. Cancer Res. 54, 4845\u20134847 (1994).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000059976","volume":"128","author":"T Shuin","year":"1999","unstructured":"Shuin, T. et al. Germline and somatic mutations in von Hippel\u2013Lindau disease gene and its significance in the development of kidney cancer. Contrib. Nephrol. 128, 1\u201310 (1999).","journal-title":"Contrib. Nephrol."},{"key":"BFnrc885_CR17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","volume":"7","author":"JR Gnarra","year":"1994","unstructured":"Gnarra, J. R. et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet. 7, 85\u201390 (1994).","journal-title":"Nature Genet."},{"key":"BFnrc885_CR18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0046-8177(97)90075-7","volume":"28","author":"A Vortmeyer","year":"1997","unstructured":"Vortmeyer, A. et al. von Hippel\u2013Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel\u2013Lindau disease. Hum. Pathol. 28, 540\u2013543 (1997).","journal-title":"Hum. Pathol."},{"key":"BFnrc885_CR19","first-page":"620","volume":"146","author":"Z Zhuang","year":"1995","unstructured":"Zhuang, Z. et al. A microscopic dissection technique for archival DNA analysis of specific cell populations in lesions &lt;1mm in size. Am. J. Path. 146, 620\u2013625 (1995).","journal-title":"Am. J. Path."},{"key":"BFnrc885_CR20","first-page":"838","volume":"9","author":"Z Zhuang","year":"1996","unstructured":"Zhuang, Z. et al. Detection of von Hippel\u2013Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. Mod Pathol 9, 838\u2013842 (1996).","journal-title":"Mod Pathol"},{"key":"BFnrc885_CR21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/(SICI)1098-2264(199807)22:3<200::AID-GCC5>3.0.CO;2-#","volume":"22","author":"S Clifford","year":"1998","unstructured":"Clifford, S., Prowse, A., Affara, N., Buys, C. & Maher, E. Inactivation of the von Hippel\u2013Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200\u2013209 (1998).","journal-title":"Genes Chromosom. Cancer"},{"key":"BFnrc885_CR22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","volume":"3","author":"K Foster","year":"1994","unstructured":"Foster, K. et al. Somatic mutations of the von Hippel\u2013Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma. Hum. Mol. Genet. 3, 2169\u20132173 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrc885_CR23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/(SICI)1098-1004(1999)13:6<464::AID-HUMU6>3.0.CO;2-A","volume":"13","author":"C Gallou","year":"1999","unstructured":"Gallou, C. et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464\u2013475 (1999).","journal-title":"Hum. Mutat."},{"key":"BFnrc885_CR24","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","volume":"91","author":"JG Herman","year":"1994","unstructured":"Herman, J. G. et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl Acad. Sci. USA 91, 9700\u20139704 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR25","first-page":"2089","volume":"149","author":"IA Lubensky","year":"1996","unstructured":"Lubensky, I. A. et al. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel\u2013Lindau disease patients. Am. J. Pathol. 149, 2089\u20132094 (1996).","journal-title":"Am. J. Pathol."},{"key":"BFnrc885_CR26","first-page":"2852","volume":"54","author":"T Shuin","year":"1994","unstructured":"Shuin, T. et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel\u2013Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res. 54, 2852\u20132855 (1994).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR27","first-page":"1092","volume":"55","author":"JM Whaley","year":"1994","unstructured":"Whaley, J. M. et al. Germ-line mutations in the von Hippel\u2013Lindau tumor suppressor gene are similar to somatic von Hippel\u2013Lindau abberations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092\u20131102 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrc885_CR28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","volume":"346","author":"H Neumann","year":"2002","unstructured":"Neumann, H. et al. Germ-line mutations in nonsyndromic pheochromocytoma. N. Engl. J. Med. 346, 1459\u20131466 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc885_CR29","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJM199311183292103","volume":"329","author":"HPH Neumann","year":"1993","unstructured":"Neumann, H. P. H. et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel\u2013Lindau disease. N. Engl. J. Med. 329, 1531\u20131538 (1993).","journal-title":"N. Engl. J. Med."},{"key":"BFnrc885_CR30","first-page":"4568","volume":"85","author":"B Bender","year":"2000","unstructured":"Bender, B. et al. Differential genetic alterations in von Hippel\u2013Lindau syndrome-associated and sporadic pheochromocytomas. J. Clin. Endocrinol. Metab. 85, 4568\u20134574 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrc885_CR31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/hmg\/6.7.1051","volume":"6","author":"E Woodward","year":"1997","unstructured":"Woodward, E. et al. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Hum. Mol. Genet. 6, 1051\u20131056 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrc885_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2265.1997.3251150.x","volume":"47","author":"M Bar","year":"1997","unstructured":"Bar, M. et al. Sporadic phaeochromocytomas are rarely associated with germline mutations in the von Hippel\u2013Lindau and RET genes. Clin Endocrinol 47, 707\u2013712 (1997).","journal-title":"Clin Endocrinol"},{"key":"BFnrc885_CR33","first-page":"4101","volume":"82","author":"H Brauch","year":"1997","unstructured":"Brauch, H. et al. Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the RET protooncogene. J. Clin. Endocrinol. Metab. 82, 4101\u20134104 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrc885_CR34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G. Tumor suppression by the human von Hippel\u2013Lindau gene product. Nature Med. 1, 822\u2013826 (1995).This paper was the first to identify the  VHL  gene product, pVHL, in cells, and the first to show that restoring pVHL function in  VHL\u2212\/\u2212 renal carcinoma cells suppressed their ability to form tumours in nude mice.","journal-title":"Nature Med."},{"key":"BFnrc885_CR35","doi-asserted-by":"crossref","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","volume":"95","author":"O Iliopoulos","year":"1998","unstructured":"Iliopoulos, O., Ohh, M. & Kaelin, W. pVHL19 is a biologically active product of the von Hippel\u2013Lindau gene arising from internal translation initiation. Proc. Natl Acad. Sci. USA 95, 11661\u201311666 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR36","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/sj.onc.1202473","volume":"18","author":"C Blankenship","year":"1999","unstructured":"Blankenship, C., Naglich, J., Whaley, J., Seizinger, B. & Kley, N. Alternate choice of initiation codon produces a biologically active product of the von Hippel\u2013Lindau gene with tumor suppressor activity. Oncogene 18, 1529\u20131535 (1999).","journal-title":"Oncogene"},{"key":"BFnrc885_CR37","doi-asserted-by":"crossref","first-page":"8817","DOI":"10.1073\/pnas.95.15.8817","volume":"95","author":"A Schoenfeld","year":"1998","unstructured":"Schoenfeld, A., Davidowitz, E. & Burk, R. A second major native von Hippel\u2013Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc. Natl Acad. Sci. USA 95, 8817\u20138822 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR38","first-page":"231","volume":"75","author":"M Los","year":"1996","unstructured":"Los, M. et al. Expression pattern of the von Hippel\u2013Lindau protein in human tissues. Lab. Invest. 75, 231\u2013238 (1996).","journal-title":"Lab. Invest."},{"key":"BFnrc885_CR39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0046-8177(97)90035-6","volume":"28","author":"CL Corless","year":"1997","unstructured":"Corless, C. L., Kibel, A., Iliopoulos, O. & Kaelin, W. G. J. Immunostaining of the von Hippel\u2013Lindau gene product (pVHL) in normal and neoplastic human tissues. Hum. Pathol. 28, 459\u2013464 (1997).","journal-title":"Hum. Pathol."},{"key":"BFnrc885_CR40","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/MCB.19.2.1486","volume":"19","author":"S Lee","year":"1999","unstructured":"Lee, S. et al. Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel\u2013Lindau tumor suppressor protein. Mol. Cell. Biol. 19, 1486\u20131497 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR41","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1074\/jbc.275.12.8991","volume":"275","author":"I Groulx","year":"2000","unstructured":"Groulx, I., Bonicalzi, M. & Lee, S. Ran-mediated nuclear export of the von Hippel\u2013Lindau tumor suppressor protein occurs independently of its assembly with cullin-2. J. Biol. Chem. 275, 8991\u20139000 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1074\/jbc.M008295200","volume":"12","author":"M Bonicalzi","year":"2001","unstructured":"Bonicalzi, M., Groulx, I., de Paulsen, N. & Lee, S. Role of exon 2-encoded \u03b2-domain of the von Hippel\u2013Lindau tumor suppressor protein. J Biol Chem 12, 1407\u20131416 (2001).","journal-title":"J Biol Chem"},{"key":"BFnrc885_CR43","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1073\/pnas.92.14.6459","volume":"92","author":"DR Duan","year":"1995","unstructured":"Duan, D. R. et al. Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc. Natl Acad. Sci. USA 92, 6459\u20136463 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR44","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","volume":"269","author":"DR Duan","year":"1995","unstructured":"Duan, D. R. et al. Inhibition of transcriptional elongation by the VHL tumor suppressor protein. Science 269, 1402\u20131406 (1995).This paper and reference  47  were the first to show that pVHL binds to elongins B and C.","journal-title":"Science"},{"key":"BFnrc885_CR45","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","volume":"94","author":"A Pause","year":"1997","unstructured":"Pause, A. et al. The von Hippel\u2013Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl Acad. Sci. USA 94, 2156\u20132161 (1997).This paper and reference  48  were the first to show that the pVHL complex also contains CUL2, and therefore provided an indication that pVHL might be involved in polyubiquitylation.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR46","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.96.17.9533","volume":"96","author":"A Pause","year":"1999","unstructured":"Pause, A., Peterson, B., Schaffar, G., Stearman, R. & Klausner, R. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL\/elongin BC\/hCUL-2 complex with the ubiquitin ligase complex SKP1\/cullin\/F-box protein. Proc. Natl Acad. Sci. USA 96, 9533\u20139538 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR47","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","volume":"269","author":"A Kibel","year":"1995","unstructured":"Kibel, A., Iliopoulos, O., DeCaprio, J. D. & Kaelin, W. G. Binding of the von Hippel\u2013Lindau tumor suppressor protein to elongin B and C. Science 269, 1444\u20131446 (1995).","journal-title":"Science"},{"key":"BFnrc885_CR48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/MCB.18.2.732","volume":"18","author":"KM Lonergan","year":"1998","unstructured":"Lonergan, K. M. et al. Regulation of hypoxia-inducible mRNAs by the von Hippel\u2013Lindau protein requires binding to complexes containing elongins B\/C and Cul2. Mol. Cell. Biol. 18, 732\u2013741 (1998).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR49","first-page":"4544","volume":"55","author":"T Kishida","year":"1995","unstructured":"Kishida, T., Stackhouse, T. M., Chen, F., Lerman, M. I. & Zbar, B. Cellular proteins that bind the von Hippel\u2013Lindau disease gene product: mapping of binding domains and the effect of missense mutations. Cancer Res. 55, 4544\u20134548 (1995).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80098-7","volume":"86","author":"C Bai","year":"1996","unstructured":"Bai, C. et al. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86, 263\u2013274 (1996).","journal-title":"Cell"},{"key":"BFnrc885_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.cellbio.15.1.435","volume":"15","author":"R Deshaies","year":"1999","unstructured":"Deshaies, R. SCF and Cullin\/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15, 435\u2013467 (1999).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrc885_CR52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins, C. E., Kaelin, W. G. & Pavletich, N. P. Structure of the VHL\u2013elongin-C\u2013elongin-B complex: implications for VHL tumor suppressor function. Science 284, 455\u2013461 (1999).This paper described the three-dimensional structure of the pVHL\u2013elongin-B\u2013elongin-C complex, which revealed the presence of two frequently mutated subdomains, \u03b1 and \u03b2.","journal-title":"Science"},{"key":"BFnrc885_CR53","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1101\/gad.13.14.1822","volume":"13","author":"J Lisztwan","year":"1999","unstructured":"Lisztwan, J., Imbert, G., Wirbelauer, C., Gstaiger, M. & Krek, W. The von Hippel\u2013Lindau tumor suppressor protein is a component of an E3 ubiquitin\u2013protein ligase activity. Genes Dev. 13, 1822\u20131833 (1999).","journal-title":"Genes Dev."},{"key":"BFnrc885_CR54","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1073\/pnas.96.22.12436","volume":"96","author":"K Iwai","year":"1999","unstructured":"Iwai, K. et al. Identification of the von Hippel\u2013Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl Acad. Sci. USA 96, 12436\u201312441 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","volume":"284","author":"T Kamura","year":"1999","unstructured":"Kamura, T. et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284, 657\u2013661 (1999).","journal-title":"Science"},{"key":"BFnrc885_CR56","first-page":"2299","volume":"56","author":"G Siemeister","year":"1996","unstructured":"Siemeister, G. et al. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel\u2013Lindau tumor suppressor protein. Cancer Res. 56, 2299\u20132301 (1996).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR57","doi-asserted-by":"crossref","first-page":"10589","DOI":"10.1073\/pnas.93.20.10589","volume":"93","author":"JR Gnarra","year":"1996","unstructured":"Gnarra, J. R. et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the VHL tumor suppressor gene product. Proc. Natl Acad. Sci. USA 93, 10589\u201310594 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR58","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/00005072-199711000-00009","volume":"56","author":"R Stratmann","year":"1997","unstructured":"Stratmann, R., Krieg, M., Haas, R. & Plate, K. Putative control of angiogenesis in hemangioblastomas by the von Hippel\u2013Lindau tumor suppressor gene. J. Neuropathol. Exp. Neurol. 56, 1242\u20131252 (1997).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc885_CR59","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","volume":"93","author":"O Iliopoulos","year":"1996","unstructured":"Iliopoulos, O., Jiang, C., Levy, A. P., Kaelin, W. G. & Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel\u2013Lindau protein. Proc. Natl Acad. Sci. USA 93, 10595\u201310599 (1996).This paper showed that cells lacking pVHL produced high levels of hypoxia-inducible mRNAs irrespective of changes in oxygen. In keeping with this, references  56  and  57  reported that cells lacking pVHL overproduce VEGF mRNA.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR60","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.cellbio.15.1.551","volume":"15","author":"G Semenza","year":"1999","unstructured":"Semenza, G. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551\u2013578 (1999).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrc885_CR61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"P Maxwell","year":"1999","unstructured":"Maxwell, P. et al. The von Hippel\u2013Lindau gene product is necessary for oxgyen-dependent proteolysis of hypoxia-inducible factor-\u03b1 subunits. Nature 399, 271\u2013275 (1999).A landmark paper showing that cells lacking pVHL do not degrade HIF-\u03b1 subunits.","journal-title":"Nature"},{"key":"BFnrc885_CR62","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"M Cockman","year":"2000","unstructured":"Cockman, M. et al. Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733\u201325741 (2000).This paper and references  63\u201365  were the first to show directly that pVHL polyubiquitylates HIF-\u03b1 subunits.","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh, M. et al. Ubiquitination of HIF requires direct binding to the von Hippel\u2013Lindau protein \u03b2-domain. Nature Cell Biol. 2, 423\u2013427 (2000).","journal-title":"Nature Cell Biol."},{"key":"BFnrc885_CR64","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","volume":"97","author":"T Kamura","year":"2000","unstructured":"Kamura, T. et al. Activation of HIF1\u03b1 ubiquitination by a reconstituted von Hippel\u2013Lindau tumor suppressor complex. Proc. Natl Acad. Sci. USA 97, 10430\u201310435 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR65","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"K Tanimoto","year":"2000","unstructured":"Tanimoto, K., Makino, Y., Pereira, T. & Poellinger, L. Mechanism of regulation of the hypoxia-inducible factor-1\u03b1 by the von Hippel\u2013Lindau tumor suppressor protein. EMBO J. 19, 4298\u20134309 (2000).","journal-title":"EMBO J."},{"key":"BFnrc885_CR66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).This paper and reference  67  were the first to show that the interaction of pVHL with HIF-\u03b1 is regulated by oxygen-dependent prolyl hydroxylation.","journal-title":"Science"},{"key":"BFnrc885_CR67","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-\u03b1 to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"BFnrc885_CR68","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","volume":"98","author":"F Yu","year":"2001","unstructured":"Yu, F., White, S., Zhao, Q. & Lee, F. HIF1\u03b1 binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl Acad. Sci. USA 98, 9630\u20139635 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR69","first-page":"4136","volume":"61","author":"F Yu","year":"2001","unstructured":"Yu, F., White, S., Zhao, Q. & Lee, F. Dynamic, site-specific interaction of hypoxia-inducible factor-1\u03b1 with the von Hippel\u2013Lindau tumor suppressor protein. Cancer Res. 61, 4136\u20134142 (2001).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR70","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon, W. C. et al. Structural basis for the recognition of hydroxyproline in HIF1\u03b1 by pVHL. Nature 417, 975\u2013978 (2002).This paper and reference  71  report the structure of pVHL bound to HIF-1\u03b1, and explain the requirement for prolyl hydroxylation.","journal-title":"Nature"},{"key":"BFnrc885_CR71","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"J-H Min","year":"2002","unstructured":"Min, J.-H. et al. Structure of a pVHL\u2013HIF1\u03b1 complex: hydroxyproline recognition in intracellular signaling. Science 296, 1886\u20131889 (2002).","journal-title":"Science"},{"key":"BFnrc885_CR72","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0959-440X(99)00036-6","volume":"9","author":"CJ Schofield","year":"1999","unstructured":"Schofield, C. J. & Zhang, Z. Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr. Opin. Struct. Biol. 9, 722\u2013731 (1999).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrc885_CR73","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0945-053X(98)90009-9","volume":"16","author":"KI Kivirikko","year":"1998","unstructured":"Kivirikko, K. I. & Myllyharju, J. Prolyl 4-hydroxylases and their protein disulfide isomerase subunit. Matrix Biol. 16, 357\u2013368 (1998).","journal-title":"Matrix Biol."},{"key":"BFnrc885_CR74","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-1119(01)00633-3","volume":"275","author":"MS Taylor","year":"2001","unstructured":"Taylor, M. S. Characterization and comparative analysis of the EGLN gene family. Gene 275, 125\u2013132 (2001).","journal-title":"Gene"},{"key":"BFnrc885_CR75","unstructured":"Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian HIF prolyl hydroxylase. Proc. Natl Acad. Sci. USA (in the press)."},{"key":"BFnrc885_CR76","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1069825","volume":"295","author":"R Bruick","year":"2002","unstructured":"Bruick, R. & McKnight, S. Transcription. Oxygen sensing gets a second wind. Science 295, 807\u2013808 (2002).","journal-title":"Science"},{"key":"BFnrc885_CR77","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1126\/science.1068592","volume":"295","author":"D Lando","year":"2002","unstructured":"Lando, D. et al. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science 295, 858\u2013861 (2002).","journal-title":"Science"},{"key":"BFnrc885_CR78","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1128\/MCB.22.9.2984-2992.2002","volume":"22","author":"N Sang","year":"2002","unstructured":"Sang, N., Fang, J., Srinivas, V., Leshchinsky, I. & Caro, J. Carboxyl-terminal transactivation activity of hypoxia-inducible factor-1\u03b1 is governed by a von Hippel\u2013Lindau protein-independent, hydroxylation-regulated association with p300\/CBP. Mol. Cell. Biol. 22, 2984\u20132992 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR79","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1073\/pnas.082117899","volume":"99","author":"S Freedman","year":"2002","unstructured":"Freedman, S. et al. Structural basis for recruitment of CBP\/p300 by hypoxia-inducible factor-1\u03b1. Proc. Natl Acad. Sci. USA 99, 5367\u20135372 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR80","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1073\/pnas.082121399","volume":"99","author":"S Dames","year":"2002","unstructured":"Dames, S., Martinez-Yamout, M., de Guzman, R., Dyson, H. & Wright, P. From the cover: structural basis for HIF-1\u03b1\/CBP recognition in the cellular hypoxic response. Proc. Natl Acad. Sci. USA 99, 5271\u20135276 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR81","doi-asserted-by":"crossref","first-page":"26351","DOI":"10.1074\/jbc.C200273200","volume":"277","author":"KS Hewitson","year":"2002","unstructured":"Hewitson, K. S. et al. Hypoxia-inducible Factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351\u201326355 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR82","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1038\/sj.onc.1204012","volume":"19","author":"C Wykoff","year":"2000","unstructured":"Wykoff, C., Pugh, C., Maxwell, P., Harris, A. & Ratcliffe, P. Identification of novel hypoxia dependent and independent target genes of the von Hippel\u2013Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 19, 6297\u20133605 (2000).","journal-title":"Oncogene"},{"key":"BFnrc885_CR83","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1074\/jbc.275.10.6922","volume":"275","author":"E Gothie","year":"2000","unstructured":"Gothie, E., Richard, D., Berra, E., Pages, G. & Pouyssegur, J. Identification of alternative spliced variants of human hypoxia-inducible factor-1\u03b1. J. Biol. Chem. 275, 6922\u20136927 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR84","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/hmg\/10.10.1019","volume":"10","author":"M Hoffman","year":"2001","unstructured":"Hoffman, M. et al. von Hippel\u2013Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum. Mol. Genet. 10, 1019\u20131027 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrc885_CR85","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1101\/gad.914801","volume":"15","author":"D Elson","year":"2001","unstructured":"Elson, D. et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1\u03b1. Genes Dev. 15, 2520\u20132532 (2001).","journal-title":"Genes Dev."},{"key":"BFnrc885_CR86","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/01.CIR.102.18.2255","volume":"102","author":"K Vincent","year":"2000","unstructured":"Vincent, K. et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1\u03b1\/VP16 hybrid transcription factor. Circulation 102, 2255\u20132261 (2000).","journal-title":"Circulation"},{"key":"BFnrc885_CR87","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/bbrc.1999.1347","volume":"263","author":"H Okuda","year":"1999","unstructured":"Okuda, H. et al. Direct interaction of the \u03b2-domain of VHL tumor suppressor protein with the regulatory domain of atypical PKC isotypes. Biochem. Biophys. Res. Commun. 263, 491\u2013497 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrc885_CR88","doi-asserted-by":"crossref","first-page":"43611","DOI":"10.1074\/jbc.M107880200","volume":"276","author":"H Okuda","year":"2001","unstructured":"Okuda, H. et al. The von Hippel\u2013Lindau (VHL) tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J. Biol. Chem. 276, 43611\u201343617 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR89","doi-asserted-by":"crossref","first-page":"27509","DOI":"10.1074\/jbc.272.44.27509","volume":"272","author":"S Pal","year":"1997","unstructured":"Pal, S., Claffey, K., Dvorak, H. & Mukhopadhyay, D. The von Hippel\u2013Lindau gene product inhibits vascular permeability factor\/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272, 27509\u201327512 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR90","doi-asserted-by":"crossref","first-page":"26277","DOI":"10.1074\/jbc.273.41.26277","volume":"273","author":"S Pal","year":"1998","unstructured":"Pal, S., Claffey, K., Cohen, H. & Mukhopadhyay, D. Activation of Sp1-mediated vascular permeability factor\/vascular endothelial growth factor transcription requires specific interaction with protein kinase C. J. Biol. Chem. 273, 26277\u201326280 (1998).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR91","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/bbrc.1999.1767","volume":"266","author":"H Cohen","year":"1999","unstructured":"Cohen, H. et al. An important von Hippel\u2013Lindau tumor suppressor domain mediates Sp1-binding and self-association. Biochem. Biophys. Res. Commun. 266, 43\u201350 (1999).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrc885_CR92","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1128\/MCB.17.9.5629","volume":"17","author":"D Mukhopadhyay","year":"1997","unstructured":"Mukhopadhyay, D., Knebelmann, B., Cohen, H., Ananth, S. & Sukhatme, V. The von Hippel\u2013Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cell. Biol. 17, 5629\u20135639 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR93","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1097-2765(00)80233-6","volume":"4","author":"D Feldman","year":"1999","unstructured":"Feldman, D., Thulasiraman, V., Ferreyra, R. & Frydman, J. Formation of the VHL\u2013elongin-B\/C tumor suppressor complex is mediated by the chaperonin TRiC. Mol. Cell 4, 1051\u20131061 (1999).","journal-title":"Mol. Cell"},{"key":"BFnrc885_CR94","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1128\/MCB.22.6.1947-1960.2002","volume":"22","author":"W Hansen","year":"2002","unstructured":"Hansen, W. et al. Diverse effects of mutations in exon II of the von Hippel\u2013Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity. Mol. Cell. Biol. 22, 1947\u20131960 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR95","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","volume":"1","author":"M Ohh","year":"1998","unstructured":"Ohh, M. et al. The von Hippel\u2013Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell 1, 959\u2013968 (1998).","journal-title":"Mol. Cell"},{"key":"BFnrc885_CR96","first-page":"4957","volume":"58","author":"B Lieubeau-Teillet","year":"1998","unstructured":"Lieubeau-Teillet, B. et al. von Hippel\u2013Lindau gene-mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids. Cancer Res. 58, 4957\u20134962 (1998).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR97","first-page":"2929","volume":"62","author":"M Esteban-Barragan","year":"2002","unstructured":"Esteban-Barragan, M. et al. Role of the von Hippel\u2013Lindau tumor suppressor gene in the formation of \u03b21-integrin fibrillar adhesions. Cancer Res, 62, 2929\u20132936 (2002).","journal-title":"Cancer Res,"},{"key":"BFnrc885_CR98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P","volume":"91","author":"A Schoenfeld","year":"2001","unstructured":"Schoenfeld, A., Davidowitz, E. & Burk, R. Endoplasmic reticulum\/cytosolic localization of von Hippel\u2013Lindau gene products is mediated by a 64-amino acid region. Int. J. Cancer 91, 457\u2013467 (2001).","journal-title":"Int. J. Cancer"},{"key":"BFnrc885_CR99","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/MCB.19.2.1289","volume":"19","author":"M Gorospe","year":"1999","unstructured":"Gorospe, M. et al. Protective function of von Hippel\u2013Lindau protein against impaired protein processing in renal carcinoma cells. Mol. Cell. Biol. 19, 1289\u20131300 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR100","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1128\/MCB.19.9.5902","volume":"19","author":"S Koochekpour","year":"1999","unstructured":"Koochekpour, S. et al. The von Hippel\u2013Lindau tumor suppressor gene inhibits hepatocyte growth factor\/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol. Cell. Biol. 19, 5902\u20135912 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR101","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005072-199605000-00004","volume":"55","author":"T Bohling","year":"1996","unstructured":"Bohling, T. et al. Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J. Neuropathol. Exp. Neurol. 55, 522\u2013527 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrc885_CR102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","volume":"153","author":"I Flamme","year":"1998","unstructured":"Flamme, I., Krieg, M. & Plate, K. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2\u03b1. Am. J. Pathol. 153, 25\u201329 (1998).","journal-title":"Am. J. Pathol."},{"key":"BFnrc885_CR103","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0161-6420(92)32024-X","volume":"99","author":"H Grossniklaus","year":"1992","unstructured":"Grossniklaus, H., Thomas, J., Vigneswaran, N. & Jarrett, W. H. Retinal hemangioblastoma. A histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology 99, 140\u2013145 (1992).","journal-title":"Ophthalmology"},{"key":"BFnrc885_CR104","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1006\/bbrc.1993.1885","volume":"194","author":"K Morii","year":"1993","unstructured":"Morii, K., Tanaka, R., Washiyama, K., Kumanishi, T. & Kuwano, R. Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem. Biophys. Res. Commun. 194, 749\u2013755 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrc885_CR105","first-page":"245","volume":"147","author":"G Reifenberger","year":"1995","unstructured":"Reifenberger, G., Reifenberger, J., Bilzer, T., Wechsler, W. & Collins, V. Coexpression of transforming growth factor-\u03b1 and epidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. Am. J. Pathol. 147, 245 (1995).","journal-title":"Am. J. Pathol."},{"key":"BFnrc885_CR106","first-page":"1358","volume":"55","author":"S Wizigmann-Voos","year":"1995","unstructured":"Wizigmann-Voos, S., Breier, G., Risau, W. & Plate, K. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel\u2013Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55, 1358\u20131364 (1995).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR107","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/archopht.117.5.625","volume":"117","author":"C Chan","year":"1999","unstructured":"Chan, C. et al. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch. Ophthalmol. 117, 625\u2013630 (1999).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrc885_CR108","first-page":"226","volume":"58","author":"B Knebelmann","year":"1998","unstructured":"Knebelmann, B., Ananth, S., Cohen, H. & Sukhatme, V. Transforming growth factor-\u03b1 is a target for the von Hippel\u2013Lindau tumor suppressor. Cancer Res. 58, 226\u2013231 (1998).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR109","unstructured":"Reference deleted in proof."},{"key":"BFnrc885_CR110","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.94.16.8761","volume":"94","author":"LE Benjamin","year":"1997","unstructured":"Benjamin, L. E. & Keshet, E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl Acad. Sci. USA 94, 8761\u20138766 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR111","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/emboj\/21.8.1939","volume":"21","author":"Y Dor","year":"2002","unstructured":"Dor, Y. et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21, 1939\u20131947 (2002).","journal-title":"EMBO J."},{"key":"BFnrc885_CR112","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1073\/pnas.92.17.7657","volume":"92","author":"C Drake","year":"1995","unstructured":"Drake, C. & Little, C. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl Acad. Sci. USA 92, 7657\u20137661 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR113","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","volume":"98","author":"V Haase","year":"2001","unstructured":"Haase, V., Glickman, J., Socolovsky, M. & Jaenisch, R. Vascular tumors in livers with targeted inactivation of the von Hippel\u2013Lindau tumor suppressor. Proc. Natl Acad. Sci. USA 98, 1583\u20131588 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR114","first-page":"820","volume":"51","author":"R Morita","year":"1991","unstructured":"Morita, R. et al. Allelotype of renal cell carcinoma. Cancer Res. 51, 820\u2013823 (1991).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR115","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1073\/pnas.92.7.2854","volume":"92","author":"CA Thrash-Bingham","year":"1995","unstructured":"Thrash-Bingham, C. A. et al. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes. Proc. Natl Acad. Sci. USA 92, 2854\u20132858 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR116","first-page":"5817","volume":"51","author":"R Morita","year":"1991","unstructured":"Morita, R. et al. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 51, 5817\u20135820 (1991).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR117","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/bjc.1994.44","volume":"69","author":"K Foster","year":"1994","unstructured":"Foster, K. et al. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br. J. Cancer 69, 230\u2013234 (1994).","journal-title":"Br. J. Cancer"},{"key":"BFnrc885_CR118","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.onc.1200915","volume":"14","author":"C Kenck","year":"1997","unstructured":"Kenck, C., Bugert, P., Wilhelm, M. & Kovacs, G. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas. Oncogene 14, 1093\u20131098 (1997).","journal-title":"Oncogene"},{"key":"BFnrc885_CR119","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1073\/pnas.95.3.993","volume":"95","author":"A Pause","year":"1998","unstructured":"Pause, A., Lee, S., Lonergan, K. M. & Klausner, R. D. The von Hippel\u2013Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl Acad. Sci. USA 95, 993\u2013998 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.21.3.865-874.2001","volume":"21","author":"E Davidowitz","year":"2001","unstructured":"Davidowitz, E., Schoenfeld, A. & Burk, R. VHL induces renal cell differentiation and growth arrest through integration of cell\u2013cell and cell\u2013extracellular-matrix signaling. Mol. Cell. Biol. 21, 865\u2013874 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrc885_CR121","first-page":"4804","volume":"55","author":"F Chen","year":"1995","unstructured":"Chen, F. et al. Suppression of growth of renal carcinoma cells by the von Hippel\u2013Lindau tumor suppressor gene. Cancer Res. 55, 4804\u20134807 (1995).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR122","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","volume":"1","author":"K Kondo","year":"2002","unstructured":"Kondo, K., Klco, J., Nakamura, E. & Kaelin, W. G. Inhibition of HIF is necessary for tumor suppression by the von Hippel\u2013Lindau protein. Cancer Cell 1, 237\u2013246 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc885_CR123","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","volume":"1","author":"JK Maranchie","year":"2002","unstructured":"Maranchie, J. K. et al. The contribution of VHL substrate binding and HIF1\u03b1 to the phenotype of VHL Loss in renal cell carcinoma. Cancer Cell 1, 247\u2013255 (2002).","journal-title":"Cancer Cell"},{"key":"BFnrc885_CR124","first-page":"1387","volume":"98","author":"N de Paulsen","year":"2001","unstructured":"de Paulsen, N. et al. Role of transforming growth factor-\u03b1 in VHL\u2212\/\u2212 clear cell renal carcinoma cell proliferation: a possible mechanism coupling von Hippel\u2013Lindau tumor suppressor inactivation and tumorigenesis. Proc. Natl Acad. Sci. USA 98, 1387\u20131392 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR125","first-page":"3407","volume":"49","author":"J Mydlo","year":"1989","unstructured":"Mydlo, J. et al. Expression of transforming growth factor-\u03b1 and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res. 49, 3407\u20133411 (1989).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR126","first-page":"544","volume":"7","author":"D Lager","year":"1994","unstructured":"Lager, D., Slagel, D. & Palechek, P. The expression of epidermal growth factor receptor and transforming growth factor-\u03b1 in renal cell carcinoma. Mod Pathol. 7, 544\u2013548 (1994).","journal-title":"Mod Pathol."},{"key":"BFnrc885_CR127","first-page":"386","volume":"124","author":"D Lowden","year":"1994","unstructured":"Lowden, D. et al. Renal cysts in transgenic mice expressing transforming growth factor-\u03b1. J. Lab. Clin. Med. 124, 386\u2013394 (1994).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrc885_CR128","first-page":"2881","volume":"81","author":"RMW Hofstra","year":"1996","unstructured":"Hofstra, R. M. W. et al. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J. Clin. Endocrinol. Metab. 81, 2881\u20132884 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrc885_CR129","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","volume":"12","author":"H Tian","year":"1998","unstructured":"Tian, H., Hammer, R., Matsumoto, A., Russell, D. & McKnight, S. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev. 12, 3320\u20133324 (1998).","journal-title":"Genes Dev."},{"key":"BFnrc885_CR130","doi-asserted-by":"crossref","first-page":"30109","DOI":"10.1074\/jbc.274.42.30109","volume":"274","author":"S Kroll","year":"1999","unstructured":"Kroll, S. et al. von Hippel\u2013Lindau protein induces hypoxia-regulated arrest of tyrosine hydroxylase transcript elongation in pheochromocytoma cells. J. Biol. Chem. 274, 30109\u201330114 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrc885_CR131","first-page":"1682","volume":"62","author":"A Bauer","year":"2002","unstructured":"Bauer, A., Paulding, W., Striet, J., Schnell, P. & Czyzyk-Krzeska, M. Endogenous von Hippel\u2013Lindau tumor suppressor protein regulates catecholaminergic phenotype in PC12 cells. Cancer Res. 62, 1682\u20131687 (2002).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR132","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0092-8674(00)81255-6","volume":"85","author":"SJ Field","year":"1996","unstructured":"Field, S. J. et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85, 549\u2013561 (1996).","journal-title":"Cell"},{"key":"BFnrc885_CR133","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"H Ryan","year":"1998","unstructured":"Ryan, H., Lo, J. & Johnson, R. HIF-1\u03b1 is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005\u20133015 (1998).","journal-title":"EMBO J."},{"key":"BFnrc885_CR134","first-page":"4010","volume":"60","author":"H Ryan","year":"2000","unstructured":"Ryan, H. et al. Hypoxia-inducible factor-1\u03b1 is a positive factor in solid tumor growth. Cancer Res. 60, 4010\u20134015 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR135","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","volume":"94","author":"P Maxwell","year":"1997","unstructured":"Maxwell, P. et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104\u20138109 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrc885_CR136","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1172\/JCI8849","volume":"104","author":"E Keshet","year":"1999","unstructured":"Keshet, E. & Ben-Sasson, S. Anticancer drug targets: approaching angiogenesis. J. Clin. Invest. 104, 1497\u20131501 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrc885_CR137","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1126\/science.287.5460.1969","volume":"287","author":"J Gibbs","year":"2000","unstructured":"Gibbs, J. Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969 (2000).","journal-title":"Science"},{"key":"BFnrc885_CR138","first-page":"4819","volume":"60","author":"J Drevs","year":"2000","unstructured":"Drevs, J. et al. Effects of PTK787\/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res. 60, 4819\u20134824 (2000).","journal-title":"Cancer Res."},{"key":"BFnrc885_CR139","first-page":"2957","volume":"4","author":"M Prewett","year":"1998","unstructured":"Prewett, M., Rothman, M., Feldman, M., Bander, N. & Hicklin, D. Mouse\u2013human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Clin. Cancer Res. 4, 2957\u20132966 (1998).","journal-title":"Clin. Cancer Res."},{"key":"BFnrc885_CR140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnci\/90.14.1087","volume":"90","author":"F Ciardiello","year":"1998","unstructured":"Ciardiello, F. et al. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. J. Natl Cancer Inst. 90, 1087\u20131094 (1998).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrc885_CR141","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","volume":"57","author":"W Sweeney","year":"2000","unstructured":"Sweeney, W., Chen, Y., Nakanishi, K., Frost, P. & Avner, E. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int. 57, 33\u201340 (2000).","journal-title":"Kidney Int."},{"key":"BFnrc885_CR142","unstructured":"Aiello, L. et al. Rapid and durable recovery of visual function in a patient with von Hippel\u2013Lindau syndrome and optic nerve head hemangioma following systemic treatment with the VEGF receptor inhibitor SU5416. Ophthalmology (in the press)."},{"key":"BFnrc885_CR143","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood.V99.10.3851","volume":"99","author":"S Richard","year":"2002","unstructured":"Richard, S. et al. Paradoxical secondary polycythemia in von Hippel\u2013Lindau patients treated with anti-vascular endothelial growth factor receptor therapy. Blood 99, 3851\u20133853 (2002).","journal-title":"Blood"},{"key":"BFnrc885_CR144","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S1471-4892(02)00179-0","volume":"2","author":"D Fabbro","year":"2002","unstructured":"Fabbro, D., Parkinson, D. & Matter, A. Protein tyrosine kinase inhibitors: new treatment modalities? Curr. Opin. Pharmacol. 2, 374\u2013381 (2002).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrc885_CR145","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/hc4301.097193","volume":"104","author":"JI Nwogu","year":"2001","unstructured":"Nwogu, J. I. et al. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilation after myocardial infarction. Circulation 104, 2216\u20132221 (2001).","journal-title":"Circulation"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrc885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrc885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:42:19Z","timestamp":1684453339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrc885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":145,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["BFnrc885"],"URL":"https:\/\/doi.org\/10.1038\/nrc885","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}